| CAS ID: | 1654725-02-6 |
| Molecular Formula: | C16H20N4O3S |
| Molecular Weight: | 348.4 g/mol |
| Monoisotopic Mass: | 348.126 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | |
| Analysis: | Drug repositioning mechanism analysis |
Trial Record 1
| ClinicalTrial ID | NCT02690519 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | February 24, 2016 | Last Verified | October 11, 2016 |
| Sponsor | Galapagos NV | ||
Trial Record 2
| ClinicalTrial ID | NCT02707562 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | March 14, 2016 | Last Verified | December 7, 2016 |
| Sponsor | Galapagos NV | ||
| PubChem: | 117857370 |
| ChEMBL: |